-85%

est. 2Y upside i

HealthcareSeed

AI-powered Patient Identification for Clinical Trials

Rank

#511

Sector

Healthcare IT

Est. Liquidity

~6Y

Data Quality

Data: Low

HealthKey presents a strong upside opportunity due to its innovative AI solution addressing a significant pain point in clinical trials and its Y Combinator backing.

Last updated: February 23, 2026

Bull (35%)+350%

HealthKey achieves rapid market penetration, secures significant follow-on funding, and fends off incumbent threats through strong product differentiation and network effects.

Base (25%)+100%

HealthKey grows steadily, captures a meaningful share of its SAM, and is acquired by a larger healthcare IT or pharma company within 5-7 years.

Bear (40%)-80%

HealthKey struggles with regulatory hurdles, faces intense competition from incumbents, or fails to scale its customer acquisition and is unable to raise further capital.

Est. time to liquidity~6.0 years

Preference Stack Risk

low

Based on an assumed $7.5M post-money valuation and $500K in seed funding, investors hold $500,000 in liquidation preferences, which is a relatively small amount compared to the current valuation, indicating a low preference stack risk for common shareholders.

Dilution Risk

high

As an early-stage company, HealthKey will likely undergo several more funding rounds, leading to significant dilution for early equity holders.

Secondary Liquidity

none

There is no active secondary market for HealthKey shares at this early stage.

Community

Valuation Sentiment

Our model estimates -85% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.